-- Mary Elizabeth Dallas
FRIDAY, Jan. 6 (HealthDay News) -- Two new studies from the Mayo
Clinic find that hepatitis C infection and obesity could be to
blame for a surge in liver cancer cases, which have tripled over
the last 30 years.
Late-stage hepatocellular carcinoma (HCC), or liver cancer, has
only a 10 percent to 12 percent five-year survival rate, according
to figures in a Mayo news release. The researchers say their
findings could help doctors diagnose the disease earlier and save
Both studies appear in the January issue of
Mayo Clinic Proceedings
"The studies illuminate the importance of identifying people with risk factors in certain populations to help catch the disease in its early, treatable stages," said Dr. W. Ray Kim, a gastroenterology and hepatology specialist and principal investigator of one study, in the release.
The researchers examined several decades of medical information
from the Rochester Epidemiology Project -- a national database on
inpatient and outpatient care. Although the U.S. National Cancer
Institute estimates the rate of HCC is 5.1 cases per 100,000
people, the new study found a higher rate of 6.9 per 100,000.
The researchers also found that hepatitis C is a risk factor for
HCC. "The liver scarring from hepatitis C can take 20 to 30 years
to develop into cancer," Kim said. "We're now seeing cancer
patients in their 50s and 60s who contracted hepatitis C 30 years
ago and didn't even know they were infected."
The study also showed that 11 percent of HCC cases were linked
to obesity, particularly fatty liver disease. "It's a small
percentage of cases overall," Kim noted. "But with the nationwide
obesity epidemic, we believe the rates of liver cancer may
dramatically increase in the foreseeable future."
In a separate study, the researchers examined Somalis living in
the United States, since Somalia is known to have a high rate of
hepatitis B, another risk factor for HCC. The study found that a
significant percentage of liver cancer cases among the Somalis were
linked not only to hepatitis B but to hepatitis C as well.
"The study suggests that screening for hepatitis C would be helpful for the Somali population and would enable close surveillance of liver cancer among those at risk," said study lead author Abdirashid Shire in the release. "That would greatly improve treatment and survival of Somalis with this type of cancer."
The U.S. National Institutes of Health provides more information
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.